InfoLogix, Inc. (NASDAQ: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, September 15, 2010 at the New York Palace Hotel in New York, NY at 10:00 a.m. Eastern.
David Gulian, InfoLogix president and CEO, will be presenting an InfoLogix corporate and investor overview, including progress on the company’s transformation to a full solutions provider business model. Mr. Gulian will also share insight on how the company has successfully elevated its higher margin consulting and professional services, such as those for Electronic Medical Records implementations, SAP® Supply Chain Execution implementations, and mobilization services, to their greatest proportion of InfoLogix’s revenue mix in company history. At the Rodman & Renshaw Annual Global Investment Conference, more than 550 public and private companies from around the world are expected to present to an audience of over 3,500 attendees.
The Conference will include corporate presentations and Q & A sessions, investor one-on-one meetings and daily networking opportunities. Institutional investors, venture capitalists, private equity firms , business development executives and sophisticated private investors can register online at the Rodman & Renshaw conference website at www.rodm.com/conferences. About InfoLogix, Inc. InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes.
With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company (NASDAQ: IFLG). Safe Harbor InfoLogix makes forward-looking statements in this press release which represent our expectations or beliefs about future events and financial performance.
Forward-looking statements are identifiable by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, including the risks described in our Annual Report on Form 10-K for the period ended December 31, 2009, the quarterly report on Form 10-Q for the period ended March 31, 2010, the quarterly report on Form 10-Q for the period ended June 30, 2010, and other filings we make with the Securities and Exchange Commission.
In addition, actual results could differ materially from those suggested by the forward-looking statements, and therefore you should not place undue reliance on the forward-looking statements. We do not make any commitment to revise or update any forward-looking statements to reflect events or circumstances occurring or existing after the date of any forward-looking statement is made. Contact for InfoLogix: John A. Roberts Chief Financial Officer 215-604-0691 x1102
Latest from Healthcare Technology Magazine News
- Global Healthcare IT Market Will Grow At A CAGR Of 5.7% to 2018
- BRHC Supports Centralisation Of Specialist Paediatric Services With Three New C-arms
- Procura Group of Companies Leads US Market
- CellTrak™ Achieves Major Milestone in roll-out of Latest Platform
- Introducing First-of-a-Kind PhysIQ Predictive Analytic Technology for Proactive Health Monitoring